We are proud to introduce a new, exciting collaboration between the International Thyroid Oncology Group (ITOG) and the American Thyroid Association (ATA) published in "Clinical Thyroidology"
In it, Dr. Jochen Lorch, MD, MS at Dana-Farber Cancer Institute, a medical oncologist and member of both the ATA and ITOG, discusses the scientific research related to thyroid cancer.
|December 2019 ||"The long road ahead: A phase 2 study of Pembrolizumab combined with Chemoradiotherapy as initial treatment for Anaplastic Thyroid Cancer"|| |
|July 2019||"Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma"|| |
| || || |